
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study
Bella Kaufman, Maureen Trudeau, Ahmad Awada, Kimberly Blackwell, Thomas Bachelot, Vanessa Salazar, Michelle DeSilvio, Ronald Westlund, Tal Zaks, Neil Spector, Stephen JohnstonVolume:
10
Année:
2009
Langue:
english
DOI:
10.1016/s1470-2045(09)70087-7
Fichier:
PDF, 500 KB
english, 2009